Sinopharm
1099.HK
$4.11
Share price
0.22%
Change (1 day)
-5.56%
Change (1 year)
Categories
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.
Market capitalization of Sinopharm (1099.HK)
Market cap: NZ$12.81 Billion
As of March 2025 Sinopharm has a market cap of NZ$12.81 Billion. This makes Sinopharm the world's 2110th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Sinopharm from 2009 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | NZ$12.81 B | -17.72% |
| 2024 | NZ$15.57 B | 20.54% |
| 2023 | NZ$12.92 B | 3.27% |
| 2022 | NZ$12.51 B | 25.92% |
| 2021 | NZ$9.93 B | -0.61% |
| 2020 | NZ$9.99 B | -37.97% |
| 2019 | NZ$16.11 B | -13.4% |
| 2018 | NZ$18.61 B | 10.48% |
| 2017 | NZ$16.84 B | 2.37% |
| 2016 | NZ$16.45 B | 1.45% |
| 2015 | NZ$16.22 B | 29.8% |
| 2014 | NZ$12.49 B | 39.37% |
| 2013 | NZ$8.96 B | -1.86% |
| 2012 | NZ$9.13 B | 23.63% |
| 2011 | NZ$7.39 B | -27.69% |
| 2010 | NZ$10.22 B | -7.73% |
| 2009 | NZ$11.07 B |
End of Day market cap according to different sources
On Mar 25th, 2025 the market cap of Sinopharm was reported to be:
NZ$13.08 Billion
NZ$13.08 Billion